The vitreous is the clear, gel-like substance that fills about 80 percent of your eyeball, sitting between the lens at the front and the retina at the back. It is mostly water, with a scaffolding of collagen fibers and a sugar molecule called hyaluronan that gives it a jelly-like consistency. Far from being an inert filler, the vitreous plays active roles in protecting the retina, regulating oxygen levels inside the eye, and maintaining the shape your eye needs to focus light properly. It also changes significantly over a lifetime, and many of the floaters, flashes, and vision complaints people develop with age trace directly back to what is happening inside this gel.
What the Vitreous Is Made Of
About 98 to 99 percent of the vitreous is water. The remaining fraction is what gives it structure: a meshwork of thin collagen fibers (primarily type II collagen, the same kind found in cartilage) interspersed with hyaluronan, a large molecule that attracts and holds water. This combination creates a transparent hydrogel with just enough rigidity to hold its shape but enough give to absorb mechanical shocks.1Taylor & Francis Online (Current Eye Research). Vitreous Humor: Composition, Characteristics and Implication on Intravitreal Drug Delivery The gel is not uniformly attached to the retina. In young people, two distinct rings of strong attachment exist around the central part of the retina: one right at the fovea (the sharp-focus center of your vision) and another just outside it. By around age 30, the inner ring has typically weakened or disappeared, leaving only the outer ring.2PubMed. Vitreomacular Attachment Ultrastructure and Histopathological Correlation That progressive loosening of the vitreous from the retina is the opening act in a lifelong process of vitreous aging.
The Oxygen Shield
One of the vitreous gel’s least obvious but most consequential jobs is keeping oxygen levels near the lens extremely low. The retina, with its dense network of blood vessels, releases a steady supply of oxygen into the eye. Because the vitreous gel resists free mixing, an oxygen gradient forms: levels are highest near the retina and fall steeply as you move toward the lens. In a normal eye, oxygen tension near the lens measures only about 9 mmHg, compared with the much higher levels found near the retina.3PubMed. Vitrectomy surgery increases oxygen exposure to the lens: a possible mechanism for nuclear cataract formation
This matters because the lens is extremely vulnerable to oxidative damage. Its proteins need to stay transparent for decades, and elevated oxygen accelerates the kind of clumping and clouding that produces cataracts. When the gel vitreous is removed surgically and replaced with saline, that physical barrier to oxygen diffusion vanishes. Oxygen from retinal blood vessels distributes freely throughout the cavity, and levels near the lens can jump roughly eightfold.4PubMed Central. Vitreoretinal influences on lens function and cataract This is a well-recognized clinical trade-off: vitrectomy can solve retinal problems but frequently leads to cataract formation afterward, sometimes within a couple of years.5Investigative Ophthalmology & Visual Science. Aging and Age-Related Diseases of the Ocular Lens and Vitreous Body
How the Vitreous Forms Before Birth
During fetal development, the vitreous cavity is threaded with a temporary blood supply called the hyaloid vasculature. These vessels nourish the developing lens and retina at a stage when the retina’s own blood vessels have not yet grown in.6PubMed Central. Assessment and Characterization of Hyaloid Vessels in Mice As the retinal vasculature matures, the hyaloid vessels are supposed to dissolve. This regression is actively triggered by retinal neurons, which sequester a growth-signaling protein called VEGF. When neuronal uptake of VEGF works normally, the hyaloid vessels lose their growth signal and wither away. When it does not, the vessels persist abnormally.7PubMed Central. Developmental regression of hyaloid vasculature is triggered by neurons
When hyaloid regression fails, the result is a condition called persistent fetal vasculature. This is a congenital malformation in which remnants of the embryonic blood supply remain inside the eye after birth, producing a spectrum of abnormalities that can affect the lens, retina, and vitreous itself.8PubMed Central. Diagnostic and Management Strategies in Patients with Persistent Fetal Vasculature: Current Insights The severity varies widely, from mild strands that cause no symptoms to dense membranes that can threaten vision and require surgery.9PubMed. Persistent Fetal Vasculature: Current Insights and Future Directions
Floaters, Liquefaction, and Why Your Vitreous Changes With Age
Starting around your twenties and accelerating from your forties onward, the vitreous gel slowly breaks down. Hyaluronan separates from its collagen scaffolding. Without hyaluronan holding them apart, collagen fibers clump together into visible strands and sheets. At the same time, pockets of pure liquid (called lacunae) form where the gel has dissolved. This dual process of collagen aggregation and gel liquefaction is what produces floaters: the clumped fibers cast shadows on the retina as they drift through the increasingly watery vitreous. Nearsighted people tend to develop these changes earlier and more severely.
As liquefaction progresses, the vitreous eventually collapses away from the retina entirely, an event called posterior vitreous detachment, or PVD. Liquid vitreous seeps through a gap in the outer shell of the gel and peels it off the retinal surface. PVD is extremely common in older adults. The event itself often announces itself with a sudden burst of new floaters, sometimes accompanied by flashing lights in your peripheral vision.
When Floaters and Flashes Signal Something Serious
Most PVDs are harmless, but the separation process can tear the retina if the vitreous is particularly sticky at certain attachment points. A systematic review found that when people showed up with classic PVD symptoms, floaters alone were associated with retinal tears in about 17 percent of eyes, and having both flashes and floaters pushed that figure to roughly 20 percent. Having more than 10 floaters or a curtain-like shadow in vision carried especially high risk.10PubMed. Symptoms related to posterior vitreous detachment and the risk of developing retinal tears: a systematic review In a large prospective study, about 10 percent of people presenting with a symptomatic PVD had a retinal tear, and just under 1 percent had already progressed to retinal detachment by the time they were examined.11Eye. Posterior vitreous detachment and retinal tear – a prospective study of community referrals
The practical takeaway: a few long-standing floaters that drift lazily across your vision on a bright day are generally benign. A sudden shower of new floaters, flashing lights (especially in one eye), or a shadow spreading across your visual field warrants an urgent eye exam. Visual impairment at presentation and the presence of bleeding inside the eye were the strongest predictors that a tear was already present.12PubMed Central. Posterior vitreous detachment – prevalence of and risk factors for retinal tears
Vitreomacular Traction and Macular Holes
Sometimes the vitreous does not peel away cleanly. If it detaches everywhere except at the macula, the small central area responsible for sharp vision, the remaining attachment point acts like a handle pulling the retina forward. This is vitreomacular traction, and it can distort the macula enough to blur or warp central vision.13PubMed Central. Partial-thickness macular hole in vitreomacular traction syndrome: a case report and review of the literature If the pulling is severe enough, it can open a full-thickness macular hole, a gap in the retina right at its most sensitive point.14PubMed Central. A review of current management of vitreomacular traction and macular hole
Both conditions can now be treated without surgery in selected cases, thanks to an injectable enzyme called ocriplasmin. This recombinant protease targets fibronectin and laminin, two proteins that help glue the vitreous to the retina. In a pivotal trial, a single injection resolved vitreomacular adhesion in about 27 percent of treated eyes versus 10 percent with placebo, and closed macular holes without surgery in roughly 41 percent of cases versus 11 percent with placebo.15PubMed. Enzymatic Vitreolysis with Ocriplasmin for Vitreomacular Traction and Macular Holes That success rate is not universal, and a smaller comparative study found vitrectomy still achieved a 100 percent resolution rate compared with about 71 percent for ocriplasmin after six months.16PubMed. Pharmaological vitreolysis with ocriplasmin as a treatment option for symptomatic focal vitreomacular traction with or without macular holes Still, for the right patient, the idea of a single injection instead of an operating room is appealing, and ocriplasmin opened the door to the broader concept of pharmacologic vitreolysis: using drugs to do what aging and surgery do mechanically.17PubMed. Ocriplasmin for pharmacologic vitreolysis
Vitreous Hemorrhage
Blood inside the vitreous cavity, known as vitreous hemorrhage, blocks light from reaching the retina and can cause anything from a few dark spots to near-total vision loss, depending on how much blood is present. The most common causes are retinal vein occlusion and retinal tears or detachment, which together account for roughly two-thirds of cases in one surgical series.18Ophthalmologica. Impact of Early Vitrectomy for Dense Vitreous Hemorrhage of Unknown Etiology Diabetic retinopathy is another frequent culprit, because abnormal new blood vessels that grow on the retinal surface are fragile and prone to rupture.
Blood in the vitreous clears on its own at a rate of roughly 1 percent per day, so a mild bleed might resolve in a few weeks to months without intervention.19PubMed Central. Vitreous hemorrhage – Causes, diagnosis, and management Dense hemorrhages, however, may need surgical removal, and evidence suggests that operating within two weeks of symptom onset produces better visual outcomes than waiting longer.20Ophthalmologica. Impact of Early Vitrectomy for Dense Vitreous Hemorrhage of Unknown Etiology
Vitrectomy and Vitreous Substitutes
Pars plana vitrectomy, the surgical removal of vitreous gel, is one of the most commonly performed retinal surgeries. Over the past two decades, instruments have shrunk dramatically. Modern “small-gauge” systems use ports just 0.5 mm wide, which means faster healing, less inflammation, and less discomfort compared with earlier approaches, while producing comparable vision outcomes.21PubMed. Small-gauge pars plana vitrectomy: a report by the American Academy of Ophthalmology These micro-incision techniques have also expanded the use of vitrectomy for inflammatory eye disease, where the procedure can remove inflammatory debris, deliver diagnostic samples, and reduce the need for systemic steroid therapy.22PubMed Central. Pars plana vitrectomy in uveitis in the era of microincision vitreous surgery
Once the vitreous is removed, the cavity needs to be filled with something. Surgeons choose from a menu of substitutes depending on the clinical goal:
- Gas bubbles: Sulfur hexafluoride or perfluoropropane are injected to press a detached retina back into place. The gas expands inside the eye, which is why patients are often told to keep their head in a specific position for days. The body gradually absorbs the gas over weeks.
- Silicone oil: Used for long-term tamponade in complex retinal detachments, silicone oil stays in the eye for months and usually requires a second surgery for removal.
- Perfluorocarbon liquids: These heavy liquids act as a “third hand” during surgery, flattening the retina while the surgeon works, but they are removed before the operation ends.
- Saline: For simpler cases, balanced salt solution fills the cavity and the eye’s own aqueous humor eventually replaces it.
None of these truly replicate the vitreous. They lack its gel structure, its oxygen-buffering properties, and its ability to remain in place indefinitely without causing tissue damage.23PubMed Central. Vitreous substitutes and tamponades – A review of types, applications, and future directions Efforts to create a permanent vitreous replacement using collagen gels, hyaluronic acid formulations, and synthetic hydrogels have been underway for years, but none has reached clinical viability yet.24Survey of Ophthalmology. Vitreous substitutes: A review Hydrogel-based substitutes remain the most active area of research, because their high water content and tunable mechanical properties make them the closest analog to natural vitreous.25PubMed Central. Hydrogel-Based Vitreous Substitutes
Sparkles and Snowflakes Inside the Eye
Two uncommon conditions produce visible particles floating in the vitreous, and they are easily confused with each other despite being quite different. Asteroid hyalosis involves tiny white particles made of hydroxyapatite and phospholipids that are embedded in the vitreous gel. Because they are attached to the gel, they swing with eye movement and return to their original positions, like ornaments on a Christmas tree. The condition is most common in older adults and almost never affects vision or requires treatment.
Synchysis scintillans, by contrast, consists of cholesterol crystals that float freely in a liquefied vitreous. These golden, glittering particles settle to the bottom of the eye with gravity when the eye is still. Synchysis scintillans tends to occur in younger people and is usually secondary to other eye disease or trauma, rather than appearing on its own.26PubMed Central. A Rare Association: Neovascular Glaucoma Accompanying Anterior Chamber Synchysis Scintillans
Imaging the Vitreous
For a structure that is meant to be invisible, the vitreous is surprisingly hard to image. Standard clinical examination with a slit lamp can reveal gross abnormalities, but subtle changes in the gel or at its boundary with the retina require more advanced tools. Optical coherence tomography (OCT) can produce cross-sectional images with micrometer-level detail when the eye’s media are clear, while ultrasound imaging takes over when blood or dense opacities block the light path.27PubMed. Imaging the vitreous: optical coherence tomography and ultrasound imaging Swept-source OCT, a newer generation of the technology, has improved the ability to detect whether the vitreous is still attached to the retina or has begun to separate.28PubMed Central. Swept Source Optical Coherence Tomography Compared to Ultrasound and Biomicroscopy for Diagnosis of Posterior Vitreous Detachment
A practical challenge is that conventional OCT display settings are optimized for the retina, which is dense and highly reflective, while the vitreous is nearly transparent and produces very faint signals. Specialized “vitreous window” display modes can boost the sensitivity for detecting vitreous features by roughly 20 percent compared with standard settings.29PLOS ONE. Enhanced Vitreous Imaging in Healthy Eyes Using Swept Source Optical Coherence Tomography This kind of imaging refinement matters for catching early vitreomacular traction or subtle PVD before symptoms become severe.
The Vitreous as a Drug Delivery Route
Injecting medication directly into the vitreous has become one of the most common procedures in ophthalmology. Anti-VEGF drugs for wet macular degeneration and diabetic eye disease are delivered this way, and the vitreous itself shapes how those drugs distribute and how long they last. Because the gel resists free mixing, a drug injected into the center of the vitreous spreads slowly by diffusion rather than being swept around by fluid currents. Modeling studies show that drug concentrations in the vitreous are roughly ten times higher than in the aqueous humor at the front of the eye, and the slow diffusion outward gives intravitreal injections a sustained-release effect that would be impossible to achieve with eyedrops or systemic dosing.30PubMed Central. Pharmacokinetic Simulations of Intravitreal Biologicals: Aspects of Drug Delivery to the Posterior and Anterior Segments
This also means the vitreous’s physical state influences drug behavior. In an elderly patient whose vitreous has largely liquefied, or in someone who has had a vitrectomy, an injected drug mixes and clears faster because there is no gel structure to slow diffusion. Computational models of drug movement after injection show that even small fluid currents during the injection process shift the drug bolus slightly forward in the eye.31Investigative Ophthalmology & Visual Science. Drug Distribution After Intravitreal Injection: A Mathematical Model Understanding these dynamics is increasingly important as researchers design longer-lasting drug implants and depot formulations meant to reduce the burden of monthly injections.
Forensic Uses of Vitreous Fluid
Outside of ophthalmology, the vitreous has found an unlikely second career in forensic pathology. After death, the gel’s semi-enclosed environment changes in predictable ways. Potassium, normally kept at low concentrations in the vitreous (about 3.5 to 5.0 mmol/L during life), leaks steadily from surrounding cells as their membranes break down. The resulting rise in vitreous potassium follows a roughly linear pattern over the first few days, and forensic scientists have developed regression formulas that use a measured potassium level to estimate how many hours have passed since death.32PubMed Central. Review of Postmortem Interval Estimation Using Vitreous Humor: Past, Present, and Future
The method is not perfectly precise, and temperature, cause of death, and individual variation all introduce error. But vitreous fluid has a key advantage over blood for postmortem chemistry: because it sits inside a sealed compartment and is relatively isolated from bacteria and decomposition enzymes, its composition stays more stable than blood’s for longer after death. Newer sensing techniques continue to refine the accuracy of these estimates.33Scientific Reports. Estimation of postmortem interval by vitreous potassium evaluation with a novel fluorescence aptasensor Vitreous fluid can also be tested for drugs, alcohol, and glucose, making it a useful backup sample when blood is contaminated or unavailable.
Infection Inside the Vitreous
Because the vitreous is a warm, protein-rich, poorly circulated gel, it provides an ideal growth medium for bacteria that manage to get inside the eye. This is the essence of endophthalmitis, an infection of the eye’s interior that can destroy vision within days if untreated. The most common route of entry is during eye surgery or intravitreal injection, though penetrating injuries and, rarely, bloodstream infections can also deliver bacteria to the vitreous cavity. Treatment typically involves injecting antibiotics directly into the vitreous and, in severe cases, performing an emergency vitrectomy to physically remove the infected material. The immune response itself can be as damaging as the bacteria, with inflammatory cells flooding into the vitreous and releasing enzymes that injure the retina.34PubMed Central. Bacterial endophthalmitis: therapeutic challenges and host-pathogen interactions The risk of endophthalmitis after modern small-gauge vitrectomy appears similar to the rate seen with older surgical techniques, though early concerns about slightly higher rates with 25-gauge instruments were addressed by changes in surgical practice over time.35PubMed. Small-gauge pars plana vitrectomy: a report by the American Academy of Ophthalmology